Cargando…
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study
Autores principales: | Stranzl, Thomas, Ipsen, Henrik, Christensen, Lars Harder, Eiwegger, Thomas, Johansen, Niels, Lund, Kaare, Andersen, Peter Sejer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246736/ https://www.ncbi.nlm.nih.gov/pubmed/31989625 http://dx.doi.org/10.1111/all.14200 |
Ejemplares similares
-
Simplified AIT for allergy to several tree pollens—Arguments from the immune outcome analyses following treatment with SQ tree SLIT‐tablet
por: Würtzen, Peter Adler, et al.
Publicado: (2020) -
A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group
por: Couroux, Peter, et al.
Publicado: (2018) -
IgE-mediated food allergy
por: Waserman, Susan, et al.
Publicado: (2018) -
Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019) -
Cow's Milk Allergy: the Relevance of IgE
por: Tosca, Maria Angela, et al.
Publicado: (2016)